Author

Mike Recher

University of BaselORCID 0000-0002-9121-6936Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Benjamin G. HaleiD· 1 shared Boris Korablev· 1 shared Eric J. AirdiD· 1 shared Jacob E. CorniD· 1 shared Julius RabliD· 1 shared Kevin GroeniD· 1 shared Lynn ScherpeiD· 1 shared Robin HupferiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Benjamin G. HaleORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SP110 sequestration of SP100 protects against toxic filaments during innate immune signaling

Eric J. Aird, Julius Rabl, Tabea Knuesel, Kevin Groen, Samah W. Awwad, Boris Korablev, Lynn Scherpe, Waleed Al–Herz, Robin Hupfer, Mike Recher, Stephen P. Jackson, Benjamin G. Hale, Jacob E. Corn

The paper identifies SP110 as a negative regulator of type 1 interferon-driven cell death by counteracting SP100's toxic filament formation through CARD domain interactions.

Nature Cell Biology · Mar 13, 2026Peer-reviewedImmunology